Back to search results

Targeting Agonists of Glucagon-like Peptide-1 Receptor for Multiple Sclerosis

Abroad (travel likely)RecruitingPHASE2

Conditions

Multiple Sclerosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Johns Hopkins University, Baltimore, Maryland, United States

    Contact: Study coordinator (Margaret Vieira) · mvieira4@jh.edu · 667-306-8153
    Contact: Principal Investigator (Ellen Mowry, MD, MCR)

  • Mount Sinai School of Medicine, New York, New York, United States

    Contact: Study coordinator (Susan Filomena) · susan.e.filomena@mssm.edu · 212-241-4364
Study leads

  • Ellen M Mowry, MD, MCR

    Principal Investigator

    Johns Hopkins University

View source on ClinicalTrials.gov(opens in a new tab)